Duvoid

   
Google
 
Web NewDrugInformation.com

Duvoid


Drug - Duvoid
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Bethanechol Chloride
Multiple ingredients are in alphabetical order.

Strength - 25MG
The potency of the active ingredient(s), Bethanechol Chloride. May repeat for multiple part products.

Applicant - WELLSPRING PHARM
The firm name holding legal responsibility for Duvoid. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 086263
The FDA assigned number to Duvoid. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Duvoid. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AA
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Duvoid was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Duvoid. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Duvoid is in. Format is RX, OTC, DISCN.

Applicant Full Name - Wellspring Pharmaceutical Corp
The full name of the firm holding legal responsibility for the new application of Duvoid.

Duvoid